カテゴリー： QYResearch, 世界, 医療/バイオ

経口溶解ストリップのグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム

◆英語タイトル：Global Orally Dissolving Strip Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8211）◆商品コード：QYR23MA8211
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：103
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の経口溶解ストリップ市場について調査・分析し、世界の経口溶解ストリップ市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（口腔分散性フィルム、口腔粘膜フィルム）、用途別セグメント分析（病院/クリニック、ドラッグストア、Eコマース）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Aquestive Therapeutics、Kyukyu Pharmaceutical、BioDelivery(BDSI)、IntelGenx、Tapemark、Shilpa Therapeutics、CL Pharm、Lubrizol Life Science、Adhex Pharma、DK Livkon、Arx Pharma、Aavishkar、ZIM Laboratories、Umang Pharmaceuticals、Cure Pharmaceuticalなどが含まれています。世界の経口溶解ストリップ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、経口溶解ストリップ市場規模を推定する際に考慮しました。

・経口溶解ストリップ市場の概要
- 製品の定義
- 経口溶解ストリップのタイプ別セグメント
- 世界の経口溶解ストリップ市場規模：タイプ別分析（口腔分散性フィルム、口腔粘膜フィルム）
- 経口溶解ストリップの用途別セグメント
- 世界の経口溶解ストリップ市場規模：用途別分析（病院/クリニック、ドラッグストア、Eコマース）
- 世界の経口溶解ストリップ市場規模予測（2018年-2029年）
- 経口溶解ストリップの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 経口溶解ストリップ市場の競争状況およびトレンド

・経口溶解ストリップの地域別市場規模
- 北米の経口溶解ストリップ市場規模（2018年-2029年）
- アメリカの経口溶解ストリップ市場規模（2018年-2029年）
- ヨーロッパの経口溶解ストリップ市場規模（2018年-2029年）
- アジア太平洋の経口溶解ストリップ市場規模（2018年-2029年）
- 中国の経口溶解ストリップ市場規模（2018年-2029年）
- 日本の経口溶解ストリップ市場規模（2018年-2029年）
- 韓国の経口溶解ストリップ市場規模（2018年-2029年）
- インドの経口溶解ストリップ市場規模（2018年-2029年）
- オーストラリアの経口溶解ストリップ市場規模（2018年-2029年）
- 中南米の経口溶解ストリップ市場規模（2018年-2029年）
- 中東・アフリカの経口溶解ストリップ市場規模（2018年-2029年）

・タイプ別セグメント：口腔分散性フィルム、口腔粘膜フィルム
- 世界の経口溶解ストリップのタイプ別販売量（2018年-2023年）
- 世界の経口溶解ストリップのタイプ別売上（2018年-2023年）
- 世界の経口溶解ストリップのタイプ別価格

・用途別セグメント：病院/クリニック、ドラッグストア、Eコマース
- 世界の経口溶解ストリップの用途別販売量（2018年-2023年）
- 世界の経口溶解ストリップの用途別売上（2018年-2023年）
- 世界の経口溶解ストリップの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Aquestive Therapeutics、Kyukyu Pharmaceutical、BioDelivery(BDSI)、IntelGenx、Tapemark、Shilpa Therapeutics、CL Pharm、Lubrizol Life Science、Adhex Pharma、DK Livkon、Arx Pharma、Aavishkar、ZIM Laboratories、Umang Pharmaceuticals、Cure Pharmaceutical

・産業チェーンと販売チャネルの分析
- 経口溶解ストリップ産業チェーン分析
- 経口溶解ストリップの主要原材料
- 経口溶解ストリップの販売チャネル
- 経口溶解ストリップのディストリビューター
- 経口溶解ストリップの主要顧客

・経口溶解ストリップ市場ダイナミクス
- 経口溶解ストリップの業界動向
- 経口溶解ストリップ市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

The films are designed to dissolve upon contact with a wet surface, such as the tongue, within a few seconds, meaning the consumer can take the product without need for additional liquid. 
Highlights
The global Orally Dissolving Strip market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Orally Dissolving Strip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Orally Dissolving Strip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Orally Dissolving Strip include Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI), IntelGenx, Tapemark, Shilpa Therapeutics, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Orally Dissolving Strip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Dissolving Strip.
The Orally Dissolving Strip market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Orally Dissolving Strip market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Dissolving Strip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Aquestive Therapeutics
Kyukyu Pharmaceutical
BioDelivery(BDSI)
IntelGenx
Tapemark
Shilpa Therapeutics
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical
Segment by Type
Orodispersible Film
Oromucosal Film
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Dissolving Strip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Dissolving Strip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Orally Dissolving Strip Market Overview
1.1 Product Overview and Scope of Orally Dissolving Strip
1.2 Orally Dissolving Strip Segment by Type
1.2.1 Global Orally Dissolving Strip Market Value Comparison by Type (2023-2029)
1.2.2 Orodispersible Film
1.2.3 Oromucosal Film
1.3 Orally Dissolving Strip Segment by Application
1.3.1 Global Orally Dissolving Strip Market Value by Application: (2023-2029)
1.3.2 Hospital and Clinic
1.3.3 Drug Store
1.3.4 E-commerce
1.4 Global Orally Dissolving Strip Market Size Estimates and Forecasts
1.4.1 Global Orally Dissolving Strip Revenue 2018-2029
1.4.2 Global Orally Dissolving Strip Sales 2018-2029
1.4.3 Global Orally Dissolving Strip Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Orally Dissolving Strip Market Competition by Manufacturers
2.1 Global Orally Dissolving Strip Sales Market Share by Manufacturers (2018-2023)
2.2 Global Orally Dissolving Strip Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Orally Dissolving Strip Average Price by Manufacturers (2018-2023)
2.4 Global Orally Dissolving Strip Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Orally Dissolving Strip, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Dissolving Strip, Product Type & Application
2.7 Orally Dissolving Strip Market Competitive Situation and Trends
2.7.1 Orally Dissolving Strip Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orally Dissolving Strip Players Market Share by Revenue
2.7.3 Global Orally Dissolving Strip Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orally Dissolving Strip Retrospective Market Scenario by Region
3.1 Global Orally Dissolving Strip Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Orally Dissolving Strip Global Orally Dissolving Strip Sales by Region: 2018-2029
3.2.1 Global Orally Dissolving Strip Sales by Region: 2018-2023
3.2.2 Global Orally Dissolving Strip Sales by Region: 2024-2029
3.3 Global Orally Dissolving Strip Global Orally Dissolving Strip Revenue by Region: 2018-2029
3.3.1 Global Orally Dissolving Strip Revenue by Region: 2018-2023
3.3.2 Global Orally Dissolving Strip Revenue by Region: 2024-2029
3.4 North America Orally Dissolving Strip Market Facts & Figures by Country
3.4.1 North America Orally Dissolving Strip Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Orally Dissolving Strip Sales by Country (2018-2029)
3.4.3 North America Orally Dissolving Strip Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Dissolving Strip Market Facts & Figures by Country
3.5.1 Europe Orally Dissolving Strip Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Orally Dissolving Strip Sales by Country (2018-2029)
3.5.3 Europe Orally Dissolving Strip Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Dissolving Strip Market Facts & Figures by Country
3.6.1 Asia Pacific Orally Dissolving Strip Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Orally Dissolving Strip Sales by Country (2018-2029)
3.6.3 Asia Pacific Orally Dissolving Strip Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Orally Dissolving Strip Market Facts & Figures by Country
3.7.1 Latin America Orally Dissolving Strip Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Orally Dissolving Strip Sales by Country (2018-2029)
3.7.3 Latin America Orally Dissolving Strip Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Dissolving Strip Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Dissolving Strip Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Orally Dissolving Strip Sales by Country (2018-2029)
3.8.3 Middle East and Africa Orally Dissolving Strip Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Orally Dissolving Strip Sales by Type (2018-2029)
4.1.1 Global Orally Dissolving Strip Sales by Type (2018-2023)
4.1.2 Global Orally Dissolving Strip Sales by Type (2024-2029)
4.1.3 Global Orally Dissolving Strip Sales Market Share by Type (2018-2029)
4.2 Global Orally Dissolving Strip Revenue by Type (2018-2029)
4.2.1 Global Orally Dissolving Strip Revenue by Type (2018-2023)
4.2.2 Global Orally Dissolving Strip Revenue by Type (2024-2029)
4.2.3 Global Orally Dissolving Strip Revenue Market Share by Type (2018-2029)
4.3 Global Orally Dissolving Strip Price by Type (2018-2029)
5 Segment by Application
5.1 Global Orally Dissolving Strip Sales by Application (2018-2029)
5.1.1 Global Orally Dissolving Strip Sales by Application (2018-2023)
5.1.2 Global Orally Dissolving Strip Sales by Application (2024-2029)
5.1.3 Global Orally Dissolving Strip Sales Market Share by Application (2018-2029)
5.2 Global Orally Dissolving Strip Revenue by Application (2018-2029)
5.2.1 Global Orally Dissolving Strip Revenue by Application (2018-2023)
5.2.2 Global Orally Dissolving Strip Revenue by Application (2024-2029)
5.2.3 Global Orally Dissolving Strip Revenue Market Share by Application (2018-2029)
5.3 Global Orally Dissolving Strip Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aquestive Therapeutics
6.1.1 Aquestive Therapeutics Corporation Information
6.1.2 Aquestive Therapeutics Description and Business Overview
6.1.3 Aquestive Therapeutics Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aquestive Therapeutics Orally Dissolving Strip Product Portfolio
6.1.5 Aquestive Therapeutics Recent Developments/Updates
6.2 Kyukyu Pharmaceutical
6.2.1 Kyukyu Pharmaceutical Corporation Information
6.2.2 Kyukyu Pharmaceutical Description and Business Overview
6.2.3 Kyukyu Pharmaceutical Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kyukyu Pharmaceutical Orally Dissolving Strip Product Portfolio
6.2.5 Kyukyu Pharmaceutical Recent Developments/Updates
6.3 BioDelivery(BDSI)
6.3.1 BioDelivery(BDSI) Corporation Information
6.3.2 BioDelivery(BDSI) Description and Business Overview
6.3.3 BioDelivery(BDSI) Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BioDelivery(BDSI) Orally Dissolving Strip Product Portfolio
6.3.5 BioDelivery(BDSI) Recent Developments/Updates
6.4 IntelGenx
6.4.1 IntelGenx Corporation Information
6.4.2 IntelGenx Description and Business Overview
6.4.3 IntelGenx Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.4.4 IntelGenx Orally Dissolving Strip Product Portfolio
6.4.5 IntelGenx Recent Developments/Updates
6.5 Tapemark
6.5.1 Tapemark Corporation Information
6.5.2 Tapemark Description and Business Overview
6.5.3 Tapemark Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tapemark Orally Dissolving Strip Product Portfolio
6.5.5 Tapemark Recent Developments/Updates
6.6 Shilpa Therapeutics
6.6.1 Shilpa Therapeutics Corporation Information
6.6.2 Shilpa Therapeutics Description and Business Overview
6.6.3 Shilpa Therapeutics Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shilpa Therapeutics Orally Dissolving Strip Product Portfolio
6.6.5 Shilpa Therapeutics Recent Developments/Updates
6.7 CL Pharm
6.6.1 CL Pharm Corporation Information
6.6.2 CL Pharm Description and Business Overview
6.6.3 CL Pharm Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CL Pharm Orally Dissolving Strip Product Portfolio
6.7.5 CL Pharm Recent Developments/Updates
6.8 Lubrizol Life Science
6.8.1 Lubrizol Life Science Corporation Information
6.8.2 Lubrizol Life Science Description and Business Overview
6.8.3 Lubrizol Life Science Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Lubrizol Life Science Orally Dissolving Strip Product Portfolio
6.8.5 Lubrizol Life Science Recent Developments/Updates
6.9 Adhex Pharma
6.9.1 Adhex Pharma Corporation Information
6.9.2 Adhex Pharma Description and Business Overview
6.9.3 Adhex Pharma Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Adhex Pharma Orally Dissolving Strip Product Portfolio
6.9.5 Adhex Pharma Recent Developments/Updates
6.10 DK Livkon
6.10.1 DK Livkon Corporation Information
6.10.2 DK Livkon Description and Business Overview
6.10.3 DK Livkon Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.10.4 DK Livkon Orally Dissolving Strip Product Portfolio
6.10.5 DK Livkon Recent Developments/Updates
6.11 Arx Pharma
6.11.1 Arx Pharma Corporation Information
6.11.2 Arx Pharma Orally Dissolving Strip Description and Business Overview
6.11.3 Arx Pharma Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Arx Pharma Orally Dissolving Strip Product Portfolio
6.11.5 Arx Pharma Recent Developments/Updates
6.12 Aavishkar
6.12.1 Aavishkar Corporation Information
6.12.2 Aavishkar Orally Dissolving Strip Description and Business Overview
6.12.3 Aavishkar Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aavishkar Orally Dissolving Strip Product Portfolio
6.12.5 Aavishkar Recent Developments/Updates
6.13 ZIM Laboratories
6.13.1 ZIM Laboratories Corporation Information
6.13.2 ZIM Laboratories Orally Dissolving Strip Description and Business Overview
6.13.3 ZIM Laboratories Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ZIM Laboratories Orally Dissolving Strip Product Portfolio
6.13.5 ZIM Laboratories Recent Developments/Updates
6.14 Umang Pharmaceuticals
6.14.1 Umang Pharmaceuticals Corporation Information
6.14.2 Umang Pharmaceuticals Orally Dissolving Strip Description and Business Overview
6.14.3 Umang Pharmaceuticals Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Umang Pharmaceuticals Orally Dissolving Strip Product Portfolio
6.14.5 Umang Pharmaceuticals Recent Developments/Updates
6.15 Cure Pharmaceutical
6.15.1 Cure Pharmaceutical Corporation Information
6.15.2 Cure Pharmaceutical Orally Dissolving Strip Description and Business Overview
6.15.3 Cure Pharmaceutical Orally Dissolving Strip Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cure Pharmaceutical Orally Dissolving Strip Product Portfolio
6.15.5 Cure Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Dissolving Strip Industry Chain Analysis
7.2 Orally Dissolving Strip Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Dissolving Strip Production Mode & Process
7.4 Orally Dissolving Strip Sales and Marketing
7.4.1 Orally Dissolving Strip Sales Channels
7.4.2 Orally Dissolving Strip Distributors
7.5 Orally Dissolving Strip Customers
8 Orally Dissolving Strip Market Dynamics
8.1 Orally Dissolving Strip Industry Trends
8.2 Orally Dissolving Strip Market Drivers
8.3 Orally Dissolving Strip Market Challenges
8.4 Orally Dissolving Strip Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 経口溶解ストリップのグローバル市場2023年：口腔分散性フィルム、口腔粘膜フィルム(Global Orally Dissolving Strip Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 口内溶解ストリップの世界市場見通し2023年-2029年
  • 口内速溶性フィルム（OFDF）の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆